TickerFacts.

Cytosorbents Corp (CTSO): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$44.18M
As of 2025-12-31
$37.96M
As of 2026-06-30
-11.3%
3-year compound annual growth
-13.3%
5-year compound annual growth
$89.95M2010-12-31: $1.81M2011-12-31: $2.12M2012-12-31: $3.34M2013-12-31: $4.05M2014-12-31: $8.47M2015-12-31: $11.25M2016-12-31: $9.69M2017-12-31: $24.10M2018-12-31: $34.20M2019-12-31: $27.38M2020-12-31: $89.95M2021-12-31: $89.52M2022-12-31: $63.23M2023-03-31: $57.46M2023-06-30: $52.44M2023-09-30: $47.58M2023-12-31: $52.96M2024-03-31: $47.07M2024-06-30: $53.43M2024-09-30: $47.80M2024-12-31: $47.37M2025-12-31: $44.18M$44.18M
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$44.18M-6.7%2026-03-30, Balance as of period end
2024-12-31$47.37Mn/a2026-03-30, Balance as of period end
2024-09-30$47.80Mn/a2025-03-31, Balance as of period end
2024-06-30$53.43Mn/a2025-03-31, Balance as of period end
2024-03-31$47.07Mn/a2025-03-31, Balance as of period end
2023-12-31$52.96Mn/a2025-03-31, Balance as of period end
2023-09-30$47.58Mn/a2025-03-31, Balance as of period end
2023-06-30$52.44Mn/a2025-03-31, Balance as of period end
2023-03-31$57.46Mn/a2025-03-31, Balance as of period end
2022-12-31$63.23M-29.4%2024-03-15, Balance as of period end
2021-12-31$89.52M-0.5%2023-03-09, Balance as of period end
2020-12-31$89.95M+228.5%2022-03-10, Balance as of period end
2019-12-31$27.38M-19.9%2021-03-09, Balance as of period end
2018-12-31$34.20Mn/c2020-03-05, Balance as of period end
2017-12-31$24.10M+148.6%2019-03-07, Balance as of period end
2016-12-31$9.69M-13.9%2018-03-08, Balance as of period end
2015-12-31$11.25M+32.9%2017-03-03, Balance as of period end
2014-12-31$8.47M+109.3%2016-03-09, Balance as of period end
2013-12-31$4.05M+21.2%2015-03-31, Balance as of period end
2012-12-31$3.34M+57.3%2014-03-31, Balance as of period end
2011-12-31$2.12M+17.1%2013-04-03, Balance as of period end
2010-12-31$1.81Mn/a2012-03-30, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Cytosorbents Corp (CTSO)2025-12-31$44.18M-6.7%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$97.75M+149.4%
Retractable Technologies Inc (RVP)2025-12-31$142.63M-11.3%
Utah Medical Products Inc (UTMD)2025-12-31$122.54M0.0%
Interpace Biosciences, Inc. (IDXG)2025-12-31$33.84M+128.8%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$114.86M+50.8%
KORU Medical Systems, Inc. (KRMD)2025-12-31$28.20M+3.6%
SS Innovations International, Inc. (SSII)2025-12-31$74.23M+75.1%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$36.05M+29.9%

Compare CTSO, CLPT, RVP, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗